Status:
COMPLETED
Functional Massage and Eccentric Exercise in Stroke Survivors (FM-EE Stroke)
Lead Sponsor:
Universitat Internacional de Catalunya
Conditions:
Stroke
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
Stroke is currently the leading cause of mortality in women, the second in men and the leading cause of disability in older adults. One of the most challenging sequelae after stroke is increased muscl...
Detailed Description
According to the WHO, stroke is the second leading cause of death and the third leading cause of disability globally, with an increasing trend in both low- and middle-income countries. The estimated g...
Eligibility Criteria
Inclusion
- Both sexes ≥ 18 years of age.
- Adults who have been diagnosed with an ischemic or hemorrhagic stroke, according to the diagnostic criteria established by the WHO; corresponding to ICD-11 in January 2022, as confirmed by CT or MRI
- Stroke ≥ 6 months
- Hospital discharge
- Stable condition
- Ability to understand and follow simple instructions
- Ability to read, write and speak Spanish or Catalan with acceptable visual and auditory acuity
- Living in the Barcelona metropolitan area
- Able to comply with scheduled visits, treatment plan, and other trial procedures
- Increased muscle tone in Lower Extremities (EEII) according to the modified Ashworth Scale (MAS) grade ≥ 1+ \<4 11) Voluntary activation capacity and muscle strength in Lower Extremities (EEII) according to Daniels Scale grade ≥ 3 12) Ability to walk 10 meters, without assistance from third parties. 13) Minimum grade of 7 in depression, 5 in anxiety and 10 in stress according to the Depression, Anxiety and Stress Scale (DASS-21).
Exclusion
- Nervous system disease and/or cardiac, pulmonary dysfunction/failure.
- History of mental disorders and/or cognitive impairment that make it difficult or impossible to follow instructions ≤ 21 Folstein's Mini Mental Test (MMSE)
- Hearing impairment
- History of psychotropic drug use in the last 6 months
- Consumption of drugs to reduce spasticity or having undergone botulinum toxin treatment in the last 3 months.
Key Trial Info
Start Date :
April 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06922149
Start Date
April 5 2025
End Date
July 1 2025
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitat Internacional de Catalunya
Sant Cugat Del Vallés, Barcelona, Spain, 08195